A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...
Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer, which ...
Mangaluru: A final-year BCA student, who is also an NCC Army Wing cadet, donated blood stem cells to assist a cancer patient in need.
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study. The experimental approach, which uses tiny capsules called small ...
Medically reviewed by Doru Paul, MD Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow. It affects cells that develop into blood cells, such as red blood cells, ...
Korean researchers have developed a technology that treats colon cancer by converting cancer cells into a state resembling normal colon cells. Listen to Story Researchers in South Korea have developed ...
Scientists found that healthy women can carry genetic changes in their breast cells that are thought to be characteristic of invasive breast cancer. Most cancer cells have too many or too few ...
The study, published today in the journal Nature Immunology, focused on chimeric antigen receptor (CAR)-T cells, an effective therapy against cancer, especially leukemia and lymphoma. T cells, a ...
However, prolonged metabolic stress allows once-senescent liver cells to start dividing and progress to cancer. A MASH-inducing diet caused DNA damage in the liver cells (hepatocytes) of MUP-uPA mice.
Cancer can begin from almost any cell in the body. The immune system usually tries to prevent it from spreading by monitoring the body for abnormal cells. White blood cells known as T-cells ...
The goal of traditional cancer treatments is to destroy cancer cells. Although this approach is often successful, it has two major drawbacks: the possibility that cancer cells will become resistant ...